Publications for Rae Reiko Matsumoto rae.matsumoto@tu.edu
Healy, J. R., Bezawada, P., Griggs, N. W., Devereaux, A. L., Matsumoto, R. R., Traynor, J. R., . . . Cunningham, C. W. (2017). Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands. Bioorganic & Medicinal Chemistry Letters, 27(3), 666-669. doi:10.1016/j.bmcl.2016.11.057
Nguyen, L., Lucke-Wold, B. P., Mookerjee, S., Kaushal, N., & Matsumoto, R. R. (2017). Sigma-1 receptors and neurodegenerative diseases: Towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection. In S. B. Smith & T. P. Su (Eds.), Sigma receptors: Their role in disease and as therapeutic targets (pp. 133-152). This material can be found here.
Palisoc, A. J. L., Matsumoto, R. R., Ho, J., Perry, P. J., Tang, T. T., & Ip, E. J. (2017). Relationship between grit with academic performance and attainment of postgraduate training in pharmacy students. American Journal of Pharmaceutical Education, 81(4) [Article 67]. This material can be found here.
Logsdon, A. F., Lucke-Wold, B. P., Nguyen, L., Matsumoto, R. R., Turner, R. C., Rosen, C. L., & Huber, J. D. (2016). Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury. Brain Research, 1643, 140-151. doi:10.1016/j.brainres.2016.04.063
Nguyen, L., Lucke-Wold, B. P., Logsdon, A. F., Scandinaro, A. L., Huber, J. D., & Matsumoto, R. R. (2016). Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice. NeuroReport, 27(14), 1004-1011. doi:10.1097/WNR.0000000000000646
Nguyen, L., Thomas, K. L., Lucke-Wold, B. P., Cavendish, J. Z., Crowe, M. S., & Matsumoto, R. R. (2016). Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics, 159, 1-22. doi:10.1016/j.pharmthera.2016.01.016
Taylor, C. P., Traynelis, S. F., Siffert, J., Pope, L. E., & Matsumoto, R. R. (2016). Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use. Pharmacology & Therapeutics, 164, 170-182. doi:10.1016/j.pharmthera.2016.04.010
Lucke-Wold, B. P., Nguyen, L., Turner, R. C., Logsdon, A. F., Chen, Y. W., Smith, K. E., . . . Matsumoto, R. R. (2015). Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure, Seizure, 33, 13-23. doi:10.1016/j.seizure.2015.10.002
Nguyen, L., & Matsumoto, R. R. (2015). Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice. Behavioral Brain Research, 295, 26-34. doi:10.1016/j.bbr.2015.03.024
Nguyen, L., Logsdon, A., Lucke-Wold, B., & Matsumoto, R. R. (2015). Behavioral and biochemical analyses of the fast acting antidepressant-like potential of dextromethorphan [Supplemental material]. FASEB Journal, 29(1), 931.2. This material can be found here.
Nguyen, L., Lucke-Wold, B. P., Mookerjee, S. A., Cavendish, J. Z., Robson, M. J, Scadinaro, A. L., & Matsumoto, R. R. (2015). Role of sigma-1 receptors in neurodegenerative disease. Journal of Pharmacological Sciences, 127(1), 17-29. doi:10.1016/j.jphs.2014.12.005
Nguyen, L., Marshalek, P. J., Weaver, C. B., Cramer, K. J., Pollard, S. E., & Matsumoto, R. R. (2015). Off-label use of transmucosal ketamine as a rapid-acting antidepressant: A retrospective chart review. Neuropsychiatric Disease and Treatment, 11, 2667-73. doi:10.2147/NDT.S88569
Scandinaro, A., Nguyen, L., & Matsumoto, R. R. (2015). Modified dextromethorphan displays antidepressant-like effects in the forced swim test [Supplemental material]. FASEB Journal, 29(1), 931.1. This material can be found here.
Healy, J. R., Tonkin, J. L., Kamarec, S. R., Saludes, M. A., Ibrahim, S. Y., Matsumoto, R. R., & Wimsatt, J. H. (2014). Evaluation of an improved sustained-release buprenorphine formulation for use in mice. American Journal of Veterinary Research, 75(7), 619-625. doi:10.2460/ajvr.75.7.619
Kaushal, N., Robson, M. J., Rosen, A., McCurdy, C. R., & Matsumoto, R. R. (2014). Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazine-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. European Journal of Pharmacology, 724, 193-203. doi:10.1016/j.ejphar.2013.12.039
Logsdon, A. F., Turner, R. C., Lucke-Wold, B. P., Robson, M. J., Naser, Z. J., Smith, K. E., . . . Matsumoto, R. R. (2014). Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in Cellular Neuroscience, 8 [Article 421]. doi:10.3389/fncel.2014.00421
Matsumoto, R. R., Nguyen, L., Kaushal, N., & Robson, M. J. (2014). Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects. Advances in Pharmacology, 69, 323-386. doi:10.1016/B978-0-12-420118-7.00009-3
Matsumoto, R. R., Seminerio, M. J., Turner, R. C., Robson, M. J., Nguyen, L., Miller, D. B., & O’Callaghan, J. P. (2014). Methamphetamine-induced toxicity: An updated review on issues related to hyperthermia. Pharmacology & Therapeutics, 144(1), 28-40. doi:10.1016/j.pharmthera.2014.05.001
Nguyen, L., Kaushal, N., Robson, M. J., & Matsumoto, R. R. (2014). Sigma receptors as potential therapeutic targets for neuroprotection. European Journal of Pharmacology, 743, 42-47. doi:10.1016/j.ejphar.2014.09.022
Nguyen, L., Robson, M. J., Healy, J. R., Scandinaro, A. L., & Matsumoto, R. R. (2014). Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. PLoS ONE, 9(2) [Article e89985]. doi:10.1371/journal.pone.0089985
Robson, M. J., Turner, R. C., Naser, Z. J., McCurdy, C. R., O'Callaghan, J. P., Huber, J. D., & Matsumoto, R. R. (2014). SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental Neurology, 254, 180-189. doi:10.1016/j.expneurol.2014.01.020
Turner, R. C., VanGilder, R. L., Naser, Z. J., Lucke-Wold, B. P., Bailes, J. E., Matsumoto, R. R., . . . Rosen, C. L. (2014). Elucidating the severity of preclinical traumatic brain injury models: A role for functional assessment? Neurosurgery, 74(4), 382-394. doi:10.1227/NEU.0000000000000292
